The reason for the prescription matters
Medicare Part D is Medicare’s drug benefit. In September 2026, its usual rules still barred cover for medicines used only for weight loss.
A weight medicine may be eligible for cover when used for another accepted health purpose, such as type 2 diabetes care or certain heart risks. That does not mean a plan has agreed to pay.
Look for the plan’s formulary: it lists which medicines the plan covers. With prior authorization, the plan must give permission before coverage can begin.
Medicare’s temporary bridge has its own route
Appetite and blood sugar respond to a signal in the body called GLP-1. Some weight and diabetes medicines copy it.
Under the Medicare GLP-1 Bridge terms dated September 2026, certain weight medicines cost $50 per month for people who qualify.
It began on July 1, 2026; its stated end date is December 31, 2027.
The Bridge sits outside Part D. Its payments do not go toward Part D’s deductible or cap on yearly spending.
A deductible is what you pay before some plan benefits start. The spending cap limits your yearly share of covered drug costs.
Eligibility also depends on the kind of plan, weight and health conditions. People with type 2 diabetes use the usual coverage route instead; that condition does not qualify them for this bridge.
Ask the plan for its answer in writing
- Is this product covered for the stated condition?
- Is permission needed before it can be covered?
- What would I pay, and what costs are outside the benefit?
- If it is declined, what is the plan’s process for reviewing that decision?
A savings card is not insurance coverage
A copay card reduces your share of an insured medicine bill. For the branded weight medicines discussed here, these cards required eligible workplace or private insurance in September 2026. They excluded people with government health coverage, including Medicare.
Those card limits do not mean a person with Medicare can never use a maker’s cash price. The cash offer and the copay card have different terms.